Board of Directors


Forsan Hussein, Chairman
Forsan Hussein is the Founder and Managing Partner of Zaitoun Ventures.  Prior to Zaitoun Ventures, Forsan was the CEO of the Jerusalem International YMCA, an institution that promotes harmony between Palestinians and Israelis since its establishment in 1878.  Forsan was also the CEO of the Three Arches Company in Jerusalem and Tiberius – a YMCA subsidiary company.
Since the age of 10, Forsan has been involved in various organizations that promote Middle East peace and foster cooperation, equality, and coexistence.  As part of his social entrepreneurship efforts, Forsan has created several international organizations including Shalam, Peace Camp Canada, Soccer for Peace, and Mabat.  Forsan worked as an investment consultant for Capital Group Companies in Los Angeles.
Currently, Forsan serves on the advisory board of a number of startups and non-profits, including Social Finance-Israel.  Forsan is a member of the Palestinian-Israeli Emerging Business Leaders Network, a Kauffman Fellow and a Young Global Leader.
Forsan holds a B.A. from Brandeis University, an M.A. from Johns Hopkins School of Advanced International Studies, and an MBA from Harvard Business School.


Qingxi Huang, Director
Mr. Huang is the Founder and Chairman of China-Israel Biological Technology Co. He has more than 23 years of entrepreneurial experience and is the chairman of many companies. He also served as a director in Hong Kong listed companies.
He has held major positions in various social platforms and was appointed as MBA master tutor of “Business school of Hunan Normal University”
Honors and Awards:
In 2005, won the “1st Top Ten Charity Enterprise Award” in Hunan Province, China
In 2006, won the “Top 10 Outstanding Youth Award in Hunan Province”


Professor Michael Eldar, External Director
Prof. Eldar was the Director of the Heart Institute and the Leviev Heart Center in Sheba Medical Center, one of Israel’s largest and most prominent hospitals. He has vast experience as a Principal Investigator in Clinical Research Studies, received numerous academic and professional awards and is a Fellow of the American College of Cardiology and European Society of Cardiology. Prof. Eldar has published over 130 peer reviewed articles as well as chapters in books, and has more than 30 years of experience in clinical research and practice.


Ms. Einav Aharoni-Yonas, Director
Ms. Einav Aharoni-Yonas is the Managing Director of Kodak Israel, Kodak’s multidisciplinary R&D center in Israel. In addition, Ms. Aharoni-Yonas is the Global Head of Innovation at Eastman Kodak Company (NYSE: KODK). Eastman Kodak Company is a technology company focused on imaging, providing hardware, software, consumables and services to customers mainly in the printing industry.
Prior to joining Kodak, Ms. Aharoni-Yonas represented high tech companies and VCs in day to day activities and in investment rounds, working for first tier law firms.
Ms. Aharoni-Yonas holds an LL.B. and B.A. in accounting from Tel Aviv University and is currently completing a Master Degree in Philosophy. She is also a qualified Mediator.
Ms. Aharoni Yonas is a member of the Management Team of 8200 Alumni Association.


Eliezer (Eli) Lavy, External Director
Eli Lavy has 20 years of experience as a senior executive in corporate management, asset management, business development, capital raising, refinancing and debt restructuring in Europe, the US and Israel.
Eli is managing I.M.C. Ltd – providing business development and investment banking services, and has served as the CEO of a Arazim Investments (a global RE public company), CEO of Giza Capital Markets Ltd the managing director of the underwriting company of Mizrahi Bank, .
Eli holds a B.Sc.E.E from the Technion, Haifa, and an MBA from Boston University.


Andrew Zhang, Director
Andrew Zhang is the CEO of China-Israel Biological Technology Co. He is a private investor, based in Israel since 2013, who also worked as a financial adviser to some major Chinese private equity funds regarding investments in Israel.
He was the senior VP and general counsel of Avantalion. Prior to that, he was the General Counsel of CA Investment Company. He participated in many Chinese-state-owned companies listed in New York.


Eitan Segal, Director
Eitan Segal is the COO of China-Israel Biological Technology Co. He served as a Foreign Affairs Director of Benjamin Netanyahu, Prime Minister of Israel.
He is also the founder and CEO of Israel SEG Group. Mr. Segal has rich political and business resources in Israel.
Mr. Segal holds a M.A. and B.A. in International relations, Magna Cum Laude from the Hebrew University. He has received the award for “Israeli intelligence services highest prize for creative thinking”.